Erenumab for chronic cluster headache: A case report
The preventive treatment for cluster headache is often limited by a lack of efficacy or side effects. Calcitonin gene-related peptide (CGRP) has been implicated in the pathophysiology of cluster headache. Galcanezumab, a monoclonal antibody against calcitonin gene-related peptide (CGRP), significant...
Saved in:
Main Authors: | Franz Riederer (Author), Allyson M Wenner (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The course of headache after the end of treatment with erenumab in patients with episodic and chronic migraine
by: Anna A. Garmanova, et al.
Published: (2024) -
Erenumab efficacy predictors for chronic migraine
by: Nina V. Vashchenko
Published: (2022) -
Lichenoid drug eruption induced by erenumab
by: Meryl Musicante, BS, et al.
Published: (2023) -
Efficacy of transdermal rotigotine in chronic cluster headache: A case series
by: Cherubino Di Lorenzo, et al.
Published: (2018) -
Evaluation of the effect of erenumab on migraine‐specific questionnaire in patients with chronic and episodic migraine
by: Po‐Wei Chen, et al.
Published: (2023)